Jipan Xie

机构：Primary Source · ORCID：0000-0001-5937-0936

发表论文 204 篇 · 总被引 3497 次 · h-index 28

代表论文

• Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States (2023 · Journal of Medical Economics · 被引 21)
• Global Assessment of Health Utilities Associated with Pneumococcal Disease in Children—Targeted Literature Reviews (2025 · PharmacoEconomics · 被引 3)
• Treatment Patterns and Adverse Event-Related Hospitalization Among Patients with Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non-small Cell Lung Cancer After Treatment with EGFR Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy Regimens (2023 · Drugs - Real World Outcomes · 被引 3)
• Real-World Treatment Patterns and Outcomes Following First-Line Pertuzumab and Trastuzumab Among Patients with HER2+ Metastatic Breast Cancer (2023 · Oncology and Therapy · 被引 1)
• EPH41 POPULATION EFFECTS OF PNEUMOCOCCAL CONJUGATE VACCINES ON INVASIVE PNEUMOCOCCAL DISEASE IN CANADA — A TARGETED LITERATURE REVIEW (2026 · Value in Health)
• Health Utilities Associated with Pneumococcal Diseases in Children and Adults: A Targeted Literature Review and Meta-analysis (2026 · PharmacoEconomics - Open)